Biotechnology Assets SA
MAD:BST

Watchlist Manager
Biotechnology Assets SA Logo
Biotechnology Assets SA
MAD:BST
Watchlist
Price: 0.28 EUR -3.45% Market Closed
Market Cap: 18.2m EUR
Have any thoughts about
Biotechnology Assets SA?
Write Note

Biotechnology Assets SA
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Biotechnology Assets SA
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Biotechnology Assets SA
MAD:BST
Common Stock
€3.2m
CAGR 3-Years
16%
CAGR 5-Years
10%
CAGR 10-Years
N/A
Grifols SA
MAD:GRF
Common Stock
€119.6m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Oryzon Genomics SA
MAD:ORY
Common Stock
€3.1m
CAGR 3-Years
5%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Pharma Mar SA
MAD:PHM
Common Stock
€11m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
No Stocks Found

Biotechnology Assets SA
Glance View

Market Cap
17.8m EUR
Industry
Biotechnology

Biotechnology Assets SA operates as a biopharmaceutical company. The company is headquartered in Jerez De La Frontera, Cadiz and currently employs 32 full-time employees. The company went IPO on 2011-06-14. The Firm’s main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The Company, through its subsidiaries, is also present in Luxembourg, Hong Kong and USA.

BST Intrinsic Value
0.29 EUR
Undervaluation 2%
Intrinsic Value
Price

See Also

What is Biotechnology Assets SA's Common Stock?
Common Stock
3.2m EUR

Based on the financial report for Jun 30, 2024, Biotechnology Assets SA's Common Stock amounts to 3.2m EUR.

What is Biotechnology Assets SA's Common Stock growth rate?
Common Stock CAGR 5Y
10%

Over the last year, the Common Stock growth was 10%. The average annual Common Stock growth rates for Biotechnology Assets SA have been 16% over the past three years , 10% over the past five years .

Back to Top